Humulin
Product Images NDC 50090-0352

43 FDA label images from A-s Medication Solutions · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 43 technical images submitted to the FDA as part of the official labeling for Humulin (NDC 50090-0352). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure (Humulin N Ifu Qr V2)

FDA Label Image

Figure (Humulin N Pen Ifu 1 V2)

Figure (Humulin N Pen Ifu 1 V2)
An instructional diagram showing the proper technique for attaching or aligning a cartridge or pen component, indicated by a red arrow pointing left. This image is likely related to the use or assembly of a Humulin N insulin delivery device.*
FDA Label Image

Figure (Humulin N Pen Ifu 10 V2)

Figure (Humulin N Pen Ifu 10 V2)
Packaging label of Humulin N insulin syringe with a green cap. The label shows the brand name Lilly and measurement markings indicating volume in units for insulin dosage. The product is labeled by A-S Medication Solutions with NDC 50090-0352.*
FDA Label Image

Figure (Humulin N Pen Ifu 11 V2)

Figure (Humulin N Pen Ifu 11 V2)
An instructional illustration showing a hand holding a syringe labeled Lilly, with an arrow indicating a turning or twisting motion on the green part of the syringe.*
FDA Label Image

Figure (Humulin N Pen Ifu 12 V2)

Figure (Humulin N Pen Ifu 12 V2)
An illustration showing a close-up of a Humulin N insulin vial with a measurement scale visible through the vial window. A red arrow points to the measurement scale, highlighting a volume between 10 and 14 units. The vial features a green cap.*
FDA Label Image

Figure (Humulin N Pen Ifu 13 V2)

Figure (Humulin N Pen Ifu 13 V2)
An instructional illustration showing a close-up view of a dosing window on an insulin pen. The window displays numbers for dosage selection, with a red arrow pointing to the number 26, indicating the chosen insulin unit setting.*
FDA Label Image

Figure (Humulin N Pen Ifu 14 V1)

Figure (Humulin N Pen Ifu 14 V1)
Illustration shows front and back views of a human figure with highlighted injection sites for Humulin N insulin. Suitable injection areas include the upper arms, abdomen, thighs, and lower back/buttocks region, indicating common subcutaneous injection sites.*
FDA Label Image

Figure (Humulin N Pen Ifu 15 V2)

Figure (Humulin N Pen Ifu 15 V2)
An instructional illustration showing a hand holding a syringe injecting into the lower abdomen area, demonstrating the proper injection site for a medication like Humulin N. The other hand is holding up a shirt to expose the injection site below the waistline.*
FDA Label Image

Figure (Humulin N Pen Ifu 16 V2)

Figure (Humulin N Pen Ifu 16 V2)
An instructional illustration showing a timer set to five seconds, indicating a five-second wait or delay.*
FDA Label Image

Figure (Humulin N Pen Ifu 18 V2)

Figure (Humulin N Pen Ifu 18 V2)
An illustration showing a close-up view of an insulin pen cartridge labeled "Lilly" with a dose window indicating an adjustable dial set to a dose between 0 and 10 units. The cartridge has a green cap. This is likely part of a dose setting diagram for an insulin pen device.*
FDA Label Image

Figure (Humulin N Pen Ifu 19 V2)

Figure (Humulin N Pen Ifu 19 V2)
An illustration showing a hand holding and preparing a pen injector device, with the cap being removed by pulling it away from the pen, indicated by a red arrow. This image likely demonstrates the first step in using the pen injector.*
FDA Label Image

Figure (Humulin N Pen Ifu 2 V2)

Figure (Humulin N Pen Ifu 2 V2)
An instructional illustration showing a hand holding a vial or cartridge with an arrow indicating a side-to-side motion. The image appears to demonstrate proper preparation or mixing technique for the product.*
FDA Label Image

Figure (Humulin N Pen Ifu 20 V2)

Figure (Humulin N Pen Ifu 20 V2)
An illustration showing a hand holding a syringe with a focus on the plunger and gradation marks. The image highlights the proper positioning or handling technique of the syringe, possibly related to dose measurement or injection procedure.*
FDA Label Image

Figure (Humulin N Pen Ifu 21 V2)

Figure (Humulin N Pen Ifu 21 V2)
Illustration showing a Humulin N insulin pen with its cap removed, exposing the dosage dial and injection button on the pen body. The image indicates how to remove the cap from the pen for use.*
FDA Label Image

Figure (Humulin N Pen Ifu 3 V2)

Figure (Humulin N Pen Ifu 3 V2)
An instructional diagram showing how to properly mix or resuspend Humulin N insulin in a vial. The illustration depicts a hand holding the vial and demonstrates the motion of rolling the vial back and forth to mix the contents gently without shaking.*
FDA Label Image

Figure (Humulin N Pen Ifu 4 V2)

Figure (Humulin N Pen Ifu 4 V2)
An instructional illustration showing a hand twisting the cap off a vial, indicated by an arrow pointing upwards to depict the removal direction. No product-specific text or branding is visible.*
FDA Label Image

Figure (Humulin N Pen Ifu 5 V2)

Figure (Humulin N Pen Ifu 5 V2)
Instructional diagram illustrating the step of attaching the protective cap to a Humulin N pen needle by twisting it on, indicating proper assembly technique for the injection device.*
FDA Label Image

Figure (Humulin N Pen Ifu 6 V3)

Figure (Humulin N Pen Ifu 6 V3)
An instructional diagram showing the proper removal and disposal of needle shields for an injection device. The illustration directs to keep the outer needle shield but throw away the inner needle shield before using the syringe needle, consistent with safe injection preparation practices.*
FDA Label Image

Figure (Humulin N Pen Ifu 7 V2)

Figure (Humulin N Pen Ifu 7 V2)
An instructional illustration showing a section of a Humulin N insulin pen with a dose window numbered 1 to 4 and a red arrow indicating upwards toward a green button or knob, likely demonstrating how to adjust or prepare a dose on the device.*
FDA Label Image

Figure (Humulin N Pen Ifu 8 V2)

Figure (Humulin N Pen Ifu 8 V2)
An instructional diagram showing a hand holding a syringe vertically and another hand flicking the syringe barrel. This illustration likely depicts how to remove air bubbles from a syringe before injection.*
FDA Label Image

Figure (Humulin N Pen Ifu 9 V2)

Figure (Humulin N Pen Ifu 9 V2)
An instructional illustration demonstrating the preparation or use of a syringe. The image shows hands holding a syringe and pressing a green stopper or cap at the bottom, with a close-up inset highlighting the proper needle insertion or attachment technique.*
FDA Label Image

Figure (Humulin N Pen Ifu Parts V3)

Figure (Humulin N Pen Ifu Parts V3)
Illustration diagram showing the parts of a Humulin N KwikPen insulin delivery device by A-S Medication Solutions. It labels the pen cap with cap clip, pen body with cartridge holder, rubber seal, plunger, and label, along with the dose knob, dose window, and dose indicator. Additionally, the pen needle parts are illustrated separately, including outer needle shield, inner needle shield, needle with paper tab, and a close-up of the dose knob.*
FDA Label Image

Figure (Humulin N Pen Ifu Pen V3)

Figure (Humulin N Pen Ifu Pen V3)
The image shows a Humulin N KwikPen insulin delivery device by Lilly. The label indicates it contains NPH insulin suspension for injection with a green and white color scheme. The pen is beige with a green cap and is designed for single patient use.*
FDA Label Image

Figure 1 (Humulin N Pi 1 V1)

Figure 1 (Humulin N Pi 1 V1)
A line graph illustrating the glucose infusion rate (mg/min/kg) over 24 hours after administration of Humulin N at a dose of 0.4 unit/kg. The graph shows an increase in glucose infusion rate peaking around 6 hours and then gradually declining over the remaining hours.*
FDA Label Image

Figure (Humulin N Vial Ifu 1 V1)

Figure (Humulin N Vial Ifu 1 V1)
An illustration depicting a vial with labeled components: a protective cap on top and a rubber stopper underneath the cap. The vial is shown empty and not containing any liquid.*
FDA Label Image

Figure (Humulin N Vial Ifu 10 V1)

Figure (Humulin N Vial Ifu 10 V1)
An instructional illustration showing the proper technique for drawing liquid from a vial with a syringe. It depicts a hand holding a vial upside down while the syringe needle is inserted into the vial to withdraw the liquid. A close-up inset shows a syringe with measurement markings indicating dosage.*
FDA Label Image

Figure (Humulin N Vial Ifu 11 V1)

Figure (Humulin N Vial Ifu 11 V1)
An instructional black and white line drawing showing two hands holding a syringe and vial, with one hand holding the vial upside down and the other pulling the syringe plunger to draw liquid from the vial. The image depicts a common preparation step for injectable medication, such as drawing insulin into a syringe.*
FDA Label Image

Figure (Humulin N Vial Ifu 12 V1)

Figure (Humulin N Vial Ifu 12 V1)
An instructional illustration showing a person drawing liquid into a syringe from a vial, with an emphasis on measuring the volume in the syringe, indicated by a separate close-up of the syringe scale marked up to 40 units.*
FDA Label Image

Figure (Humulin N Vial Ifu 13 V1)

Figure (Humulin N Vial Ifu 13 V1)
An instructional illustration showing a hand holding a syringe and vial. The image depicts drawing medication from the vial into the syringe, indicated by an upward arrow from the vial to the syringe.*
FDA Label Image

Figure (Humulin N Vial Ifu 14 V1)

Figure (Humulin N Vial Ifu 14 V1)
An instructional diagram showing recommended injection sites on the human body for Humulin N. The front view highlights the abdomen and upper thighs, while the back view shows the upper arms and buttocks as preferred injection areas.*
FDA Label Image

Figure (Humulin N Vial Ifu 15 V1)

Figure (Humulin N Vial Ifu 15 V1)
An instructional illustration demonstrating how to inject medication using a syringe into the abdominal area of a person. The image shows hands holding a syringe at the injection site located on the lower belly, with an arrow indicating the direction or placement of the injection.*
FDA Label Image

Figure (Humulin N Vial Ifu 16 V1)

Figure (Humulin N Vial Ifu 16 V1)
An instructional illustration showing a hand performing a subcutaneous injection into the abdomen area. The person receiving the injection is lifting their shirt to expose the skin, and the syringe needle is inserted at an angle indicated by an arrow.*
FDA Label Image

Figure (Humulin N Vial Ifu 17 V1)

Figure (Humulin N Vial Ifu 17 V1)
An instructional line drawing showing a hand injecting medication into the abdomen using a syringe. The image appears to illustrate the proper injection technique for subcutaneous administration, with the syringe held at an angle and the injection site on the abdominal area.*
FDA Label Image

Figure (Humulin N Vial Ifu 2 V1)

Figure (Humulin N Vial Ifu 2 V1)
Illustration showing a biohazard sharps disposal container with a lid, alongside a small vial labeled Humulin, two alcohol prep swabs, and an insulin syringe. The setup suggests preparation for insulin injection.*
FDA Label Image

Figure (Humulin N Vial Ifu 3 V1)

Figure (Humulin N Vial Ifu 3 V1)
An instructional illustration showing two hands holding a vial, with a curved double-headed arrow above indicating the vial should be gently rolled or mixed. The image demonstrates proper handling technique for Humulin N vial before use.*
FDA Label Image

Figure (Humulin N Vial Ifu 4 V1)

Figure (Humulin N Vial Ifu 4 V1)
An instructional illustration showing a hand holding a vial. The motion indicated by arrows suggests shaking or inverting the vial, likely demonstrating how to mix or prepare the liquid inside before use.*
FDA Label Image

Figure (Humulin N Vial Ifu 5 V1)

Figure (Humulin N Vial Ifu 5 V1)
An instructional illustration showing a hand holding a glass vial and the other hand removing the cap from the vial. An upward arrow indicates the direction to pull the cap off.*
FDA Label Image

Figure (Humulin N Vial Ifu 6 V1)

Figure (Humulin N Vial Ifu 6 V1)
An instructional black-and-white line drawing showing two hands holding a vial, with one hand pulling off the vial's cap. The illustration demonstrates how to remove the cap from the vial, likely as part of medication preparation steps.*
FDA Label Image

Figure (Humulin N Vial Ifu 7 V1)

Figure (Humulin N Vial Ifu 7 V1)
Illustration showing the correct technique for drawing liquid from a vial into a syringe. One hand holds the vial upside down, while the other hand pulls the syringe plunger down to draw the liquid. The syringe is marked with measurement increments for accurate dosing.*
FDA Label Image

Figure (Humulin N Vial Ifu 8 V1)

Figure (Humulin N Vial Ifu 8 V1)
An instructional illustration showing two hands performing a needle attachment onto a syringe, with an arrow indicating the direction to push the needle onto the syringe tip.*
FDA Label Image

Figure (Humulin N Vial Ifu 9 V1)

Figure (Humulin N Vial Ifu 9 V1)
An instructional illustration showing hands preparing an injection with a syringe and vial, indicating how to draw medication into the syringe. No specific product branding or labeling is visible in the image.*
FDA Label Image

Figure (Humulin N Vial Qr V1)

FDA Label Image

Label Image (Lbl500900352)

Label Image (Lbl500900352)
Humulin N label for NPH human insulin isophane suspension, 100 units per mL, 10 mL Vial. The product is distributed by A-S Medication Solutions, Libertyville, IL. The label includes instructions to refrigerate but not freeze the product.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.